CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

A brief review of Terminalia bellerica (Balela) with special reference of Unani medicine

  • Alam, Sajid (Department of Moalajat (Medicine), Sufia Unani medical college hospital and research center) ;
  • Ansari, Shabnam (Department of biotechnology, Faculty of natural sciences, Jamia Millia Islamia)
  • Received : 2019.07.25
  • Accepted : 2019.08.12
  • Published : 2019.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Unani medicine utilizes Terminalia bellerica (known as balela in Unani classics) for the treatment of diseases such as obesity, diarrhea, weakness of digestive system, ageing, greying of hairs, weakness of memory and eyesight, strengthening of immunity, general weakness etc. This paper briefly review this worthwhile drug for its general morphology, chemical constituents, dosage, pharmacological actions, therapeutic uses, compound formulations in Unani medicine and experimental studies.

Keywords

References

  1. Ahmad N, Mishra P. Effect of Terminalia bellerica against high fat diet induced hyperlipidemia and obesity. Pharmacoeconomics. 2017;2(1):62.
  2. Anonymous. Qarabadine majeedi.(New Delhi, India: Hamdard waqf Lab), pp.23-24, 88, 1986.
  3. Anonymous. The Unani Pharmacopoeia of India. Part I, Volume I. (New Delhi, India: Ministry of AYUSH), pp5-6, 17-18, 32-33, 2007.
  4. Ansari S, Khan QA, Anjum R, Siddiqui A, Sultana K. Fundamentals of Unani system of medicine - a review. European Journal of Biomedical and Pharmaceutical sciences. 2017;4(9):219-223.
  5. Deb A, Barua S, Das B. Pharmacological activities of Baheda (Terminalia bellerica): A review. Journal of Pharmacognosy and Phytochemistry. 2016;5(1): 194-7.
  6. Fatima N, Sultana H. Evaluation of protective effect of Terminalia bellerica against gentamicin induced nephrotoxicity in albino rats. Pharmaceutical and Biological Evaluations. 2016;3(5):486-4.
  7. Ghani N. Khazainul Advia. 2nd ed. (New Delhi, India: Idara Kitab us Shifa), pp.187-189, 421-422, 1352-54, 2008.
  8. Hakeem HMA. Mufradat Azeezi. (New Delhi, India: CCRUM), pp. 14, 46, 103, 105, 115, 118, 2009.
  9. Hakeem MAH. Bistanul Mufradat. (New Delhi, India: Idara e Kitabul Shifa), pp.72, 100, 347-48, 1999.
  10. Kabeeruddin HM. Biyaz Kabir. Vol 2. Hyderabad, India: Hikmat Book Depo), pp 5, YNM.
  11. Kabiruddin H. Makhzan Al Mufradat. (New Delhi, India: Ejaz Publishing House), pp. 55, 145, 590-91, YNM.
  12. Khan MA. Muhite Azam(New Delhi, India: CCRUM), pp. 213-15, 740-45, 2012.
  13. Manjunatha M, Bhalodiya H, Ansari MA, Vada S, Goli D. Immunomodulatory activity of Terminalia Bellirica extract in mice. International Journal of Pharmagenesis. 2011;2(1):103-108.
  14. Pingale SS. Hepatoprotective action of Terminalia belerica on CCl4 induced hepatic disorders. Der Pharma Chemica. 2011;3(1):42-8.
  15. Pragya M , Nesar A, Tarique M, Arshiya S, Bagga P, Prashant S. Effect of Terminalia bellerica against high fat diet induced hyperlipidemia and obesity. World Journal of Pharmaceutical Sciences. 2016;4(4):33-7.
  16. Sabu MC, Kuttan R. Antidiabetic and antioxidant activity of Terminalia belerica. Roxb. Indian J Exp Biol. 2009;47(4):270-5.
  17. Tanaka M, Kishimoto Y, Saita E, Sugihara NS, Kamiya T, Taguchi C, Lida K, Kondo K. Terminalia bellirica extract inhibits low-density lipoprotein oxidation and macrophage inflammatory response in vitro. Antioxidants (Basel). 2016;5(2):20. https://doi.org/10.3390/antiox5020020